[저자] Nikolaus Jilg, Kara W Chew, Mark J Giganti, Eric S Daar, David A Wohl, Arzhang Cyrus Javan, Amy Kantor, Carlee Moser, Robert W Coombs, Gene Neytman, Keila Hoover, Atasi Jana, Phil A Hart, Alexander L Greninger, Bob Szurgot, Joseph J Eron, Judith S Currier, Michael D Hughes, Davey M Smith, Jonathan Z Li,
for the ACTIV-2/A5401 Study Team
ChewKaraSmithDavidDaarEricWohlDavidCurrierJudithEronJosephJavanArzhang CyrusHughesMichaelMoserCarleeGigantiMarkRitzJustinHoseyLaraRoaJhoannaPatelNilamColshKellyRwakazinaIreneBeckJustineSiegScottLiJonathanFletcherCourtneyFischerWilliamEveringTeresaCoombsRobertIgnacioRachel BenderCardosoSandraCoradoKatyaJagannathanPrasannaJilgNikolausPerelsonAlanPillaySandyRiviereCynthiaSinghUpinderTaiwoBabafemiGottesmanJoanNewellMatthewPedersenSusanDragavonJoanJenningsCherylGreenfelderBrianMurtaughWilliamKosmynaJanGaparaMorganShahkolahiAkbarSzurgotBob
, Kara Chew, David Smith, Eric Daar, David Wohl, Judith Currier, Joseph Eron, Arzhang Cyrus Javan, Michael Hughes, Carlee Moser, Mark Giganti, Justin Ritz, Lara Hosey, Jhoanna Roa, Nilam Patel, Kelly Colsh, Irene Rwakazina, Justine Beck, Scott Sieg, Jonathan Li, Courtney Fletcher, William Fischer, Teresa Evering, Robert Coombs, Rachel Bender Ignacio, Sandra Cardoso, Katya Corado, Prasanna Jagannathan, Nikolaus Jilg, Alan Perelson, Sandy Pillay, Cynthia Riviere, Upinder Singh, Babafemi Taiwo, Joan Gottesman, Matthew Newell, Susan Pedersen, Joan Dragavon, Cheryl Jennings, Brian Greenfelder, William Murtaugh, Jan Kosmyna, Morgan Gapara, Akbar Shahkolahi, Bob Szurgot
[Category] update2024,
[Article Type] Major Article
[Source] PMC
In a phase 2 randomized controlled trial of nonhospitalized adults with mild-to-moderate COVID-19, oral camostat did not accelerate viral clearance, time to symptom improvement, or reduce hospitalizations or deaths compared with placebo.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, Phase 2, camostat, Outpatient,